Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2) [Phase 2]
Phase 2 study ARIEL2 evaluating rucaparib in platinum-sensitive relapsed high-grade ovarian/fallopian tube/primary peritoneal cancer complet…
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: To Assess the Efficacy and Safety of Olaparib Maintenance Monotherapy in the Treatment of Ovarian Cancer [Phase 4]
Phase 4 trial assessing olaparib maintenance monotherapy in BRCA or HRR+ mutated ovarian cancer; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-06-16Clinical Trial Update: Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating intraperitoneal infusion of autologous monocytes with Sylatron (peginterferon alfa-2b) and Actimmune (interferon ga…
-
CLINICAL_TRIALS trial_result · 2021-06-14Clinical Trial Update: Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating NKTR-102 in metastatic or locally advanced ovarian cancer has completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-03Clinical Trial Update: Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian Cancer [Phase 2]
Phase 2 trial updating dose-dense paclitaxel with pembrolizumab in platinum-resistant ovarian cancer has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: A Study of ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer [Phase 3]
A Phase 3 trial evaluating ZL-2306 (niraparib) as maintenance therapy after first-line chemotherapy in advanced ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2021-06-01Clinical Trial Update: A Study of TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic Tumors [Phase 2]
Phase 2 study of TQ-B3525 tablets in gynecologic tumors with PIK3CA/PIK3R1/2 alterations (advanced endometrial, cervical, and ovarian cancer…
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: SGI-110 in Combination With Carboplatin in Ovarian Cancer [Phase 2]
Results from a Phase 2 trial of SGI-110 (guadecitabine) plus carboplatin in ovarian cancer have been completed and posted.
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: Guadecitabine and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating guadecitabine plus pembrolizumab in recurrent ovarian, primary peritoneal, or fallopian tube cancer has completed w…
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: Study of SC10914 in Patients With gBRCA1/2 Mutation Advanced Ovarian Cancer [Phase 2]
Phase 2 trial update for SC10914 in patients with gBRCA1/2-mutated advanced ovarian cancer is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates. [Phase 4]
Phase 4 trial comparing oral iron to placebo in newly diagnosed gynecologic oncology patients who are surgical candidates; completed.
-
CLINICAL_TRIALS trial_result · 2021-04-27Clinical Trial Update: Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian Cancer [Phase 2]
Phase II study of Intraperitoneal NanoPac in ovarian cancer was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: Ovarian Dendritic Cell Vaccine Trial [Phase 2]
A Phase 2 clinical trial update for an ovarian cancer dendritic cell vaccine; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: DCVAC/OvCa After Standard-of-care Chemotherapy in Women With Relapse of Platinum-sensitive Epithelial Ovarian Cancer [Phase 2]
Phase 2 trial update of DCVAC/OvCa as follow-up after standard chemotherapy in women with relapse of platinum-sensitive epithelial ovarian c…
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: Evaluation of Response to the Neoadjuvant Chemotherapy for Advanced Ovarian Cancer by Multimodal Functional Imaging [NA]
Clinical trial evaluating multimodal functional imaging to assess response to neoadjuvant chemotherapy in advanced ovarian cancer has comple…
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: Olaparib Maintenance With Pembrolizumab & Bevacizumab in BRCA Non-mutated Patients With Platinum-sensitive Recurrent Ovarian Cancer [Phase 2]
Phase 2 trial evaluating olaparib maintenance with pembrolizumab and bevacizumab in BRCA wild-type, platinum-sensitive recurrent ovarian can…
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer [Phase 3]
A Phase 3 trial evaluating sensitivity to different chemotherapy regimens in platinum-partial sensitive recurrent ovarian cancer is in progr…
-
CLINICAL_TRIALS trial_result · 2021-04-02Clinical Trial Update: Study of DP303c Injection in Patients With Advanced Ovarian Cancer [Phase 2]
Phase 2 clinical trial update for DP303c Injection in advanced ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Study of Azacitidine and Durvalumab in Advanced Solid Tumors [Phase 2]
Phase 2 study evaluating azacitidine with durvalumab in advanced solid tumors has completed enrollment with conditions including microsatell…
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer [Phase 3]
Phase 3 trial evaluating paclitaxel, polyglutamate paclitaxel, or observation in advanced ovarian, fallopian tube, or primary peritoneal can…
-
CLINICAL_TRIALS trial_result · 2021-03-25Clinical Trial Update: PD-1 Antibody Combined Neoadjuvant Chemotherapy for Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating a PD-1 antibody in combination with neoadjuvant chemotherapy for ovarian cancer; current status is unkno…
-
CLINICAL_TRIALS trial_result · 2021-03-22Clinical Trial Update: TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating tumor-infiltrating lymphocyte (TIL) therapy in combination with checkpoint inhibitors for metastatic ovarian ca…
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating chiauranib in combination with chemotherapy for ovarian cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: Short-course HIPEC in Advanced Epithelial Ovarian Cancer [Phase 2]
Phase 2 clinical trial update on short-course HIPEC for advanced epithelial ovarian cancer completed.
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: Camrelizumab /Apatinib for Recurrent Platinum-resistant Ovarian Cancer [Phase 2]
Phase 2 trial update for camrelizumab in combination with apatinib in recurrent platinum-resistant ovarian cancer.